Toth Financial Advisory Corp Invitae Corp Transaction History

Toth Financial Advisory Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$24.31 - $33.6 $4,862 - $6,720	-200 Reduced 34.19%	385 $11,000
Q1 2021 Apr 20, 2021	BUY	$33.06 - $56.93 $16,034 - $27,611	485 Added 485.0%	585 $22,000
Q4 2020 Jan 25, 2021	BUY	$39.09 - $57.4 $3,909 - $5,740	100 New	100 $4,000
Q1 2020 Apr 20, 2020	SELL	$7.64 - $27.5 $764 - $2,750	-100 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$15.02 - $20.57 $1,502 - $2,057	100 New	100 $2,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.